Antitumor polycyclic acridines. 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridines

被引:73
作者
Stanslas, J
Hagan, DJ
Ellis, MJ
Turner, C
Carmichael, J
Ward, W
Hammonds, TR
Stevens, MFG
机构
[1] Univ Nottingham, Sch Pharmaceut Sci, Canc Res Labs, Nottingham NG7 2RD, England
[2] Univ Nottingham, City Hosp, CRC, Dept Clin Oncol, Nottingham NG5 1PB, England
[3] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England
关键词
D O I
10.1021/jm9909490
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New synthetic routes to a series of tetra- and pentacyclic acridines related in structure to marine natural products are reported. The novel water-soluble agent dihydroindolizino[7,6,5-kL]acridinium chloride 14 has inhibitory activity in a panel of non-small-cell lung and breast tumor cell lines exceeding that of m-AMSA. The salt inhibited the release of minicircle products of kDNA confirming that disorganization of topoisomerase II partly underlies the activity of the compound. COMPARE analysis of the NCI mean graph profile of compound 14 at the GI(50) level corroborates this conclusion with Pearson correlation coefficients (>0.6) to clinical agents of the topoisomerase II class: however, this correlation was not seen at the LC50 level. The inhibitory action of 14 on Saccharomyces cerevisiae transfected with human topoisomerase II isoforms showed a 3-fold selectivity against the II alpha isoform over the II beta isoform. Unlike nt-AMSA, 14 is not susceptible to P-glycoprotein-mediated drug efflux and retains activity in lung cells with derived resistance to the topoisomerase II inhibitor etoposide.
引用
收藏
页码:1563 / 1572
页数:10
相关论文
共 44 条
[1]  
ABRAMOVITCH RA, J CHEM SOC CHEM COMM, P389
[2]  
ALBERT A, 1985, SELECTIVE TOXICITY
[3]  
ALVAREZ M, 1991, HETEROCYCLES, V32, P759
[4]  
ALVAREZ M, 1992, HETEROCYCLES, V34, P2385
[5]  
[Anonymous], 1966, EDWARD ARNOLD
[6]   POTENTIAL ANTITUMOR AGENTS .12. 9-ANILINOACRIDINES [J].
ATWELL, GJ ;
CAIN, BF ;
SEELYE, RN .
JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (06) :611-&
[7]  
BAGULEY BC, 1991, ANTI-CANCER DRUG DES, V6, P1
[8]   Molecular recognition between a new pentacyclic acridinium salt and DNA sequences investigated by optical spectroscopic techniques, proton nuclear magnetic resonance spectroscopy, and molecular modeling [J].
Bostock-Smith, CE ;
Giménez-Arnau, E ;
Missailidis, S ;
Laughton, CA ;
Stevens, MFG ;
Searle, MS .
BIOCHEMISTRY, 1999, 38 (21) :6723-6731
[9]  
BOSTOCKSMITH CE, 1999, P AM ASSOC CANC RES, V40, pP32
[10]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109